Contact WHS      Members Only Area     
About WHS Board of Directors

Officers

Sashwati Roy, PhD, President (2018-2019)
Sashwati Roy, PhD
Associate Professor, The Ohio State University
Surgery
511 DHLRI
473 West 12th Avenue
Columbus, OH 43210
614-247-7657 telephone
sashwati.roy@osumc.edu
President (2018-2019)

Sashwati Roy, PhD is an Associate Professor of Surgery and Director of laser capture Molecular Analysis facility at the Ohio State University Columbus Ohio. She received her PhD in 1994 in Physiology and Environmental Sciences. She completed her postdoctoral training from University of California, Berkeley. Her research interest include wound inflammation, mechanisms of resolution of diabetic wound inflammation, role of miRNA in tissue repair processes. Dr. Roy has over 150 peer review publications in high impact journals including PNAS and Journal of Immunology. She serves in the Editorial Board of several Journals such as Physiological Genomics, Antioxidants and Redox Signaling. She is an expert in significance of macrophage and inflammation in chronic wounds. Dr. Roy has recently served as a program co-chair for the annual (2013) meeting of the Wound Healing Society held in Denver, CO. She is currently appointed as the secretary for the Society. Dr. Roy’s research is funded by National Institute of Health (NIDDK, NIH) to investigate on the role of inflammation in diabetic wounds. She also serves as a co-investigator on multiple federal (NIH, DOD and VA) grants on miRNA and wound healing.

Geoffrey Gurtner, MD, FACS, President-Elect (2018-2019)
Geoffrey Gurtner, MD, FACS
Vice Chairman of Surgery for Research
Stanford University School of Medicine
257 Campus Drive West, GK-201
Stanford, CA 94305-5148
Phone 650-736-2776
Fax 650-724-9501
ggurtner@stanford.edu
President-Elect (2018-2019)

Dr. Geoffrey C. Gurtner is the Johnson and Johnson Professor of Surgery and Biomedical Engineering (by courtesy) and Materials Science (by courtesy) at Stanford University. Clinically, Dr. Gurtner is the Director of the Stanford Wound Center and the Stanford Program in Applied Regenerative Medicine (SARM). He is the author of over 280 peer-reviewed publications and is an Editor for two major textbooks in the field: Grabb & Smith's Plastic Surgery and Plastic Surgery. Dr. Gurtner was awarded the James Barrett Brown Award in both 2009 and 2010 and has been named "researcher of the year" by the ASPS, AAPS and numerous other professional organizations. Dr. Gurtner runs an NIH and DoD funded laboratory examining how physical stimuli (mechanical and chemical) alter the human response to injury. This has led to the development of new technologies for which Dr. Gurtner has received 20 issued patents and over 100 patent applications. Dr. Gurtner has founded several venture backed start-up companies, including Neodyne Biosciences (www.neodynebio.com) and Arresto Biosciences, acquired by Gilead (NASDAQ:GILD) in 2011. Dr. Gurtner was also a founding partner at Tautona Group (www.tautonagroup.com), an early stage life science fund that has created novel biomedical technologies that have been sold to industry leading companies, such as Allergan (NYSE:AGN), Novadaq (NASDAQ:NVDQ), and Acelity/KCI (San Antonio, TX).

Alan Wells, MD DMSc, Vice President (2018-2019)
Alan Wells, MD DMSc
wellsa@upmc.edu
Vice President (2018-2019)

Dr. Alan Wells is the Thomas J. Gill III Professor of Pathology and the Executive Vice-Chairman of the Department of Pathology at the University of Pittsburgh. In addition, Wells is a Professor of Bioengineering and Computational Biology (secondary appointments) and a Staff Physician at the Veterans Administration Medical Center in Pittsburgh, Pennsylvania. He also serves as the Medical Director for the UPMC System Clinical Laboratories.

Wells holds an AB in Biochemistry from Brown University (1979) and received his doctorate (DMSc) in Tumor Biology from the Karolinska Institute in Stockholm, Sweden, in 1982. Returning to Providence, Rhode Island, he received his MD from Brown University in 1988. Following his studies, Wells completed a postdoctoral fellowship in Tumor Biology at the University of California in San Francisco, California, and a Residency in Laboratory Medicine at the University of California in San Diego, California. He has won numerous awards and has been recognized locally and nationally for his research, mentoring and clinical service, including being elected to the American Society for Clinical Investigation (ASCI) and American Association of University Pathologists (AAUP/Pluto Club).

Within his laboratory, Wells and his research team are aiming to gain a better understanding of how cells respond to their local environment. Ultimately, the importance of his research flows from the provision of reinforcing insights and novel avenues for exploration into the basic signaling pathways, as well as functioning of entire organisms. Currently, Wells is concentrating his research efforts towards gaining further knowledge of the conditions of dysregulated (tumor dissemination and chemoresistance of tumors) and orchestrated (wound healing and organogenesis) responses. These studies are performed in vitro, in animal models, validating in human specimens, and employing novel state-of-the-art all human microphysiological systems.

Traci Wilgus, PhD, Secretary (2016-2019)
Traci Wilgus, PhD
Assistant Professor
The Ohio State University
Pathology
1645 Neil Avenue
129 Hamilton Hall
Columbus, OH 43210
614-366-8526 telephone
traci.wilgus@osumc.edu
Secretary (2016-2019)

Dr. Wilgus is an Assistant Professor in the Department of Pathology at The Ohio State University. She earned her Ph.D. from Ohio State and completed post-doctoral training at Loyola University Medical Center. She was a junior faculty member at University of Illinois-Chicago before accepting a tenure-track position at Ohio State in 2008. Her lab studies the role of inflammation and angiogenesis in wound healing and skin carcinogenesis, and is particularly interested in scarless fetal healing. She currently receives funding from two NIH grants. Dr. Wilgus is an ad hoc reviewer for NIH and US Army research grants, and a permanent member of the Wound panel for the Military Infectious Diseases Research Program.

Dr. Wilgus joined the Wound Healing Society as a graduate student in 2000. She served on the Website Committee (2008-2011) and is currently a member of the Awards and Program Committees. For the past five years, she has reviewed abstracts, served as a moderator, and helped organized the Meet the Mentors session for the annual meeting. She frequently reviews manuscripts for the WHS journals Wound Repair and Regeneration and Advances in Wound Care, and sits on the editorial boards for Ostomy Wound Management and Advances in Wound Care.

Herbert B. Slade, MD, Treasurer (2018-2019)
Herbert B. Slade, MD
Managing Director
Chisholm Clinical Research Services
2436 Medford Court West
Fort Worth, TX 76109
(817) 226-8760
bert.slade@ccrsbrussels.com
Treasurer (2018-)

Dr. Slade is a dual board-certified subspecialist in pediatrics and clinical immunology with more than 25 years of industry-based experience in clinical research. After holding academic appointments at the University of Michigan and Cornell University Medical Center, he was recruited from academia to work with Dr. Jonas Salk on an HIV therapeutic vaccine joint venture, taking the position of Director of AIDS and Immunology at Rhône-Poulenc Rorer.

From there Dr. Slade went on to join 3M Pharmaceuticals as Chief Medical Officer. During his twelve years at 3M, Dr. Slade oversaw the development and licensure of multiple products, including a groundbreaking new class of immune response modifiers for viral infections and cancer. When 3M sold its pharma business, Dr. Slade joined DFB Pharmaceuticals in Fort Worth, TX, where he served as Chief Medical Officer for Healthpoint Biotherapeutics. Smith & Nephew plc acquired Healthpoint in 2012, bringing Dr. Slade into the realm of medical devices in the role of CMO and Sr.VP of Research & Development for the wound care division through the end of 2016.

Dr. Slade earned his undergraduate degree in biology from Hamilton College in Clinton, N.Y., followed by his medical degree from State University of New York (SUNY) Upstate Medical University in Syracuse, N.Y.

Elof Eriksson, MD, PhD, Past President (2018-2019)
Elof Eriksson, MD, PhD
Professor Emeritus
Harvard Medical School
Chief Medical Officer
Applied Tissue Technologies
Phone number: 781-956-2353
Email: Elof@comcast.net
Past President (2018-2019)

Elof Eriksson was born in Sweden, and received his graduate medical and research training there. He then completed a general surgery residency at the University of Chicago, and a plastic surgery residency at the Medical College of Virginia. Subsequently he returned to Sweden and worked for three years in Gothenburg. He then returned to the US to be the Director of the Burn Center at Memorial Medical Center at SIU in Springfield, IL. Between 1986 and 2016 he was the Chief of Plastic Surgery at Brigham and Women's Hospital, Harvard Medical School. In 1997, he became the first Joseph E. Murray Professor of Plastic and Reconstructive Surgery. His early research dealt with microcirculation in muscle and skin. Later he focused on wound repair using gene transfer to modify signaling. Since 2016 he is doing Military Trauma Research. He has published more than 150 peer reviewed papers on Wound Healing. When he was President of the Wound Healing Foundation from 2002 – 2004, he initiated, raised the necessary funds, and helped oversee the WHS Wound Healing Guidelines project. His current research focus is on the analysis and modification of the wound microenvironment as well as keratinocyte and fibroblast transplantation for regeneration of skin after Trauma.

 

Board Members

Adrian Barbul, MD
Surgery
Vanderbilt University School of Medicine
1161 21st Avenue South
D-5203 Medical Center North
Nashville, TN 37232-2577
615-343-5613 telephone
abarbul009@gmail.com
Adrian Barbul, MD (2016-2019)

A native of Romania, Dr. Barbul graduated from the School of General Medicine in Bucharest Romania. He began his surgical residency at the Albert Einstein College of Medicine where he also completed a two year Research Fellowship in Burns and Trauma. He completed his residency at Sinai Hospital of Baltimore while also running a very productive basic science laboratory. After his residency Dr. Barbul practiced as a General and Trauma Surgeon while also establishing a wound healing research laboratory examining the influence of amino acid nutrition and immunity of the healing cascade. He has more than 30 years of experience in the study of wound healing. Although his expertise includes many of the subdiciplines of wound healing, he is perhaps most well known for his study of the role of nutrition and amino acids in wound healing.

Dr. Barbul has authored over 180 original publications, over 50 textbook chapters and has edited two books. He has presented extensively as an invited Grand Rounds presenter or at international meetings. As founding member and then as President of the Wound Healing Society, he led a team charged with the promulgation of care guidelines for arterial, diabetic, venous and pressure ulcers which have been widely disseminated, accepted and adopted.

Academically, Dr. Barbul is Professor of Surgery at the Vanderbilt University School of Medicine.

Elizabeth Grice, PhD
Assistant Professor
Dept of Dermatology and Microbiology
University of Pennsylvania
G1007 BRB II/III
421 Curie Blvd
Philadelphia, PA 19104
Office: 215-898-3179
Lab: 215-573-1095
egrice@mail.med.upenn.edu
Elizabeth Grice, PhD (2017-2020)

Elizabeth Grice, Ph.D., is an Assistant Professor of Dermatology and Microbiology in the Perelman School of Medicine at the University of Pennsylvania. She received a B.A. in Biology from Luther College, and a Ph.D. in Human Genetics from Johns Hopkins University. Dr. Grice then completed a post-doctoral fellowship at the NIH, where her pioneering work revealed the vast topographic and temporal diversity of the healthy human skin microbiome. Dr. Grice serves as an Associate Editor of Microbiome journal and is a frequent member of NIH and DoD study sections. She has received numerous awards including the NIH K99-R00 Pathway to Independence Award, the NIH Award of Merit, the Luther College Young Alumni Award, and the University of Pennsylvania Michael S. Brown New Investigator Research Award. Research in the Grice laboratory is highly collaborative and innovative, integrating microbiology, dermatology, genomics, bioinformatics, and immunology to understand host-microbe interactions of the skin during wound healing. Her research is funded by grants from both NIH and industry and encompasses clinical studies to identify microbiota that lead to poor outcomes in chronic wounds, and studies in model organisms to delineate the mechanisms by which microbes and biofilm impair wound healing.

Dennis P. Orgill, MD, PhD
Surgeon
Division of Plastic Surgery
Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115
Phone: 617-732-7874
DOrgill@BWH.Harvard.edu
Dennis P. Orgill, MD, PhD (2017-2020)

Dr. Dennis Orgill is a Plastic Reconstructive Surgeon at Brigham and Women’s Hospital (BWH). In 1978, he attended MIT as a graduate student and worked with Drs. Yannas and Burke in developing an artificial skin for burn victims. He was involved in the pre-clinical and early clinical studies performed at Massachusetts General Hospital and the Shiners Burn Institute. He completed Medical School at Harvard as well as residencies in Surgery and Plastic Surgery at BWH and Harvard. He then started on staff in the Plastic Surgery Division at BWH in 1992 where he also started the Tissue Engineering and Wound Healing Laboratory that has published over 100 papers and received numerous grants. He became the Medical Director of the newly formed BWH Wound Center in 2009. This Center has cared for thousands of patients, been involved in several clinical trials and has sponsored a bi-annual regional Wound Care Conference. In 2013 he was appointed as the only surgeon on the Board of Directors of the Hidradenitis Foundation, which advocates for better treatments of patients with this difficult disease. He looks forward to advocating for improved wound care for the many patients with acute and chronic wounds throughout the world.

Anie Philip, PhD
Montreal General Hospital
McGill University
1650 Cedar Avenue
Room C9-177
Montreal, QC H3G 1A4
Canada
514-934-1934 x44533 telephone
anie.philip@mcgill.ca
Anie Philip, PhD (2016-2019)

Anie Philip, PhD is a tenured Professor in the Department of Surgery at McGill University, Canada. She is also the Director of Plastic Surgery Research and Director of Experimental Surgery Graduate Program at McGill University, and Co-chair of the Skin Research Group Canada.

Dr Philip received her PhD from McGill and completed her post-doctoral training at the National Research Council Canada. She joined the Department of Surgery, McGill in 1994, and over the past 2 decades, her research program has focused on the molecular mechanisms of skin and cartilage repair and regeneration. Her research has been continuously funded by the Canadian Institutes of Health Research, NSERC Canada and more recently the Department of Defense USA. Her team’s recent contributions include the discovery and functional characterization of a novel TGF-b co-receptor, identification of unique regulatory mechanisms by TGF-b co-receptors in skin cells and chondrocytes. Her research is currently focused on developing novel anti-fibrotic peptides for which her team holds several patents.

Dr Philip has served the Wound Healing Society as the Annual Meeting Program Co-Chair (2010), Awards Committee Chair (2006-2009), Strategic Planning Committee member (2006-2011), and is currently a member of the Scientific Program and Website committees. As a Graduate Program Director at her University and a past WHS Awards Committee Chair, she has a special interest in advancing initiatives to promote the career development of WHS trainee members and retaining them in the area of wound healing research.

Heather Powell, PhD
Associate Professor
The Ohio State University
116 W. 19th Avenue
243 Fontana Labs
Columbus, OH 43210
614-247-8673 telephone
powell.299@osu.edu
Heather Powell, PhD (2016-2019)

Heather Powell, PhD is currently an Associate Professor at The Ohio State University in the Departments of Materials Science and Engineering and Biomedical Engineering. During the majority of her academic career, she has focused on materials for burn repair and autologous tissue engineered skin, methods for reducing scarring post burn injury, and device development for non-destructive analysis of skin.

As a skin scientist with a non-traditional background in engineering, Heather brings a unique scientific perspective to the Board of Directors and will work to develop strategies to broaden the base of the members. “Efforts to increase the appeal of the Wound Healing Society for scientists with research focuses from translational medicine to technology will not only allow for more collaborative/networking opportunities within our society but also help adapt the WHS to meet the changing needs of our members.”

Vickie Rae Driver, DPM, MS
New Indications Discovery Unit
Novartis Biomedical Research Institute
PO Box 290790
Charlestown, MA 02129
Work Phone: (253) 691-9197
drvdriver@aol.com
Vickie Rae Driver, DPM, MS

Dr Vickie R. Driver is a Fellow at the American College of Foot and Ankle Surgeons, licensed in Ma and RI and is board certified in foot surgery by the American Board of Podiatric Surgery. She has recently been nominated as Fellow, Royal College of Physicians and Surgeons-Glasgow, PM. Her career has a special emphasis on wound healing and limb preservation and she is an outspoken ambassador for progressive change in this field.

Dr. Driver is a Professor of Surgery in the Department of Orthopedics at Brown University (Clinical). She has recently completed her tenure as president for the Advancement of Wound Care Association (AAWC), and has served for 9 years on the Board of Directors. She also proudly serves as a member of the Wound Healing Society (WHS) Board of Directors- member at large and chair-Industry relations and as member Board of Directors for the Critical Limb Ischemia (CLI) Global Society and chair wound healing committee.

She has successfully chaired an initiative to expand the wound healing clinical endpoints considered by FDA. She proposed a combined effort between the WHS and AAWC to develop the Wound-care Experts/FDA-Clinical Endpoints Project [WEF-CEP] to strategically identify clinically meaningful, evidence-based and patient-centered wound care endpoints that are relevant for clinical research and trials. The goal is to collaboratively work with the FDA to expand the list of acceptable primary endpoints, recognizing that new and innovative treatments, devices and drugs may not have complete healing as the focus. Furthermore, validated endpoints other than complete healing will promote improved clinical trial design and will reduce the time for discoveries to reach our patients. Over the past three years, through ongoing interaction with the FDA InterCenter Wound Healing Work Group [ICWHWG], the WEF-CEP team has conducted a wide reaching Clinician Survey with 628 participating wound care experts, completed an extensive literature review for 28 wound care endpoints using the FDA criteria for a validated endpoint, published the clinical survey results in WRR, is in process to publish the research phase results and is currently conducting a Patient Survey to augment the findings of the Clinician Survey. Formal collaboration with the FDA established to execute on the WEF CEP work is on-going.

As principle investigator, she has served on and initiated more than 70 important multi-center randomized clinical trials, as well as developed and supervised multiple research fellowship training programs. She has co-authored over 100 publications and abstracts.

Dr. Driver is Director, Translational Medicine Wound Healing at Novartis Institute for BioMedical Research. She is dedicated to making a scientific contribution to both the understanding of the natural history of disease and the discovery of new therapies and diagnostics to advance the treatment of patients who suffer with wounds and are at risk of limb loss.

Howard Levinson, MD
General Surgeon
Plastic and Reconstructive Micro Surgeon
Duke University Medical Center (DUMC)
Durham, North Carolina
howard.levinson@duke.edu
Howard Levinson, MD (2018-2021)

Howard Levinson, MD, FACS is a double board certified General Surgeon and Plastic and Reconstructive Micro Surgeon at Duke University Medical Center (DUMC). He is an Associate Professor in the Departments of Surgery and Pathology. Dr Levinson is: (1) an expert in wound repair and scarring, (2) the Director of Plastic Surgery Research and the PI of the Wound Healing and Fibrosis Laboratory at DUMC, and (3) a nationally recognized key opinion leader. He has been an ad hoc member of multiple Department of Defense and NIH study sections, including SBIR/STTR committees, and has been PI of NIH grants, NCBiotech grants, a Coulter translational grant, a Duke Translational Medical Institute Translational Grant, and MedBlue translational grant. He holds several patents, and has expertise in translational research in the peri-operative space. He is Founder of Deep Blue Medical Advances, a medical device company whose mission is to commercial Medical Devices.

Patient Care: Dr Levinson cares for patients both at DUMC and the Veterans Administration Hospital in Durham, North Carolina. His practice is >90% reconstructive and frequently includes reconstruction of complex abdominal wall defects. He is recognized by his peers on a national level for his clinical expertise as can be noted by his serving as a speaker and moderator for multiple loco-regional and national meetings.

Director of Plastic Surgery Research: Dr Levinson's interdisciplinary team uses in vitro and in vivo pre-clinical models to understand disease pathogenesis and develop new technologies. He works closely with biomedical engineers and basic scientists on different translational projects. He designs and oversees clinical trials. His research is funded by intramural as well as extramural grants. He is past Chairman of the Plastic Surgery Foundation Research Fundamentals Workshop, Chairman of the Plastic Surgery Foundation Research Education Committee and Basic Science Study Section, and Chairman of the Plastic Surgery Research Council. He is a member of the Board of Directors for the American Society of Plastic Surgery.

Dr Levinson has consulted for GlaxoSmithKline, Johnson and Johnson, Heraeus Pharmaceuticals, Exoxemis, Allergan. He serves on the Wound Care Advisory board for Cardinal Health. He has multiple collaborations with investigators both within and outside of DUMC. He has served as an ad-hoc reviewer for several scientific journals including but not limited to The New England Journal of Medicine, Annals of Surgery, The American Journal of Physiology: Cell Physiology, e-PLOS, Journal of Surgical Research, Plastic and Reconstructive Surgery, and Molecular and Cellular Biochemistry.

Kath Bogie
kmb3@case.edu
Kath Bogie (2018-2021)

Dr. Bogie is a biomedical engineer committed to pursuing patient-centered translational research. Dr. Bogie currently holds appointments as Associate Professor in the Dept of Orthopaedics at Case Western Reserve University (CWRU) and as Senior Research Scientist at the Louis Stokes Cleveland Dept of Veterans Affairs Medical Center, where she is also Director of Health Maintenance and Monitoring within the Advanced Platform Technology Center. At CWRU, she directs the Additive Manufacturing for Biotechnology Core, supporting biomedical additive manufacturing. Dr. Bogie received her D.Phil in Biomedical Engineering from the University of Oxford, England. Her initial post-doctoral appointment was at the National Spinal Cord Injuries Centre (NSIC), Aylesbury, England, with a concurrent appointment as Associate Clinical Scientist at Queen Mary and Westfield College, University of London. At NSIC, she established a Wheelchair Seating Clinic for individuals with spinal cord injury. The multivariate quantitative non-invasive tissue health evaluation tool she developed there has since been applied in multiple clinical studies. At NSIC, she noticed that many wheelchair users were prevented from achieving their full functional potential due to tissue health problems. The huge detriment on all aspects of the affected individual's life motivated her to dedicate her career to the multiple challenges of wound management. Dr. Bogie's lab works on primary and secondary prevention of chronic wounds through novel clinically –focused approaches. The overarching goal is to reduce the fear of developing a chronic non-healing wound. Dr. Bogie has received continuous support for her research program for over 17 years, including funding from the DoD Spinal Cord Injury Research Program, the Dept. of Veterans Affairs Rehabilitation Service and the Craig H Neilsen Foundation. Current translational research includes studies to determine why some people experience a continuous cycle of pressure injuries while others remain pressure injury free, complemented with smart technology development to address these issues. Dr. Bogie has been recognized internationally as an expert in research areas related to wound care, has published over 50 papers and book chapters and given multiple national and international presentations. Dr Bogie is on the Editorial Boards of Journal of Tissue Viability and the Journal of Rehabilitation and Assistive Technologies Engineering and is an active referee for multiple scientific journals and numerous other national and international grant review panels.

Dr. Bogie joined the Wound Healing Society in 2011, and has served as an active member of the Education Committee since joining WHS. As a biomedical engineer working on translational studies in wound care, Dr. Bogie is committed to building effective interdisciplinary teamwork. There are a wealth of basic science and early clinical trials being carried out in wound care research, but all too often these fail to translate, in part due to lack of communication between different specialties. The Wound Healing Society is the home that fosters interactions. Moving outside our silos of expertise and working with others allows the field to gain from diversity of experience. As a member of the WHS Board of Directors, Dr. Bogie looks forward to working to enhance interdisciplinary interactions in wound care research.

Rivkah Isseroff
rrisseroff@ucdavis.edu
Rivkah Isseroff (2018-2021)

Bio coming soon...

Representing Wound Healing Society Foundation on the Board of Directors

Laura K.S. Parnell Laura K.S. Parnell Ex-Officio
Founder & President
Precision Consulting
6522 Harbor Mist
Missouri City, TX 77459
281-208-3037 Telephone
281-208-8193 fax
l-parnell@earthlink.net

Representing Wound Repair and Regeneration on the Board of Directors

Jeffrey M. Davidson, PhD Jeffrey M. Davidson, PhD Ex Officio
Editor in Chief, Wound Repair and Regeneration
Professor of Pathology, Microbiology and Immunology
Vanderbilt University School of Medicine
1161 21St. Ave. S
Nashville, TN 37232-2561
O: 615-496-8900
jeff.davidson@vanderbilt.edu
  Brian Eliceiri, PhD Brian Eliceiri, PhD Ex-Officio
Publications Committee Chair
Department of Surgery
University of California San Diego
212 Dickinson Street, MC 8236
San Diego, CA 92103
O:619-543-2905
L:619-543-2903
beliceiri@ucsd.edu